CONBA: Perindopril and Amlodipine Tablets (Ⅲ) have obtained the drug registration certificate
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, CONBA announced that recently, its wholly-owned subsidiary Hangzhou CONBA Pharmaceutical Co., Ltd. (hereinafter referred to as "Hangzhou CONBA") received the drug registration certificate for Perindopril Amlodipine Tablets (III) issued by the National Medical Products Administration (hereinafter referred to as "NMPA")
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments